Skip to content

Resistance Training in People Living With HIV/AIDS

Effects of Resistance Training in People Living With HIV/AIDS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03879993
Enrollment
49
Registered
2019-03-19
Start date
2018-03-01
Completion date
2019-02-28
Last updated
2019-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Keywords

Exercise, Cognition, Body composition, Inflammatory biomarkers, CD4

Brief summary

The aim of this study will be to verify effects of resistance training in people living with HIV/AIDS.

Detailed description

The aim of this study was verify effects of resistance training in cognitive function, body composition and biochemical parameters of inflammation and oxidative stress in people living with HIV/AIDS. The sample was composed by patients with HIV/AIDS of both sexes. The patients were randomized in two groups, a exercise group (EG), which was receive intervention with eight weeks of resistance training, and a control group (CG), that was not to do exercise. The cognitive function was analyzed with Stroop Test and Trail Test; body composition was evaluated by bioimpedance; blood tests was use to analyze biochemical parameters of inflammation and oxidative stress. For statistical analysis was used ANOVA of two factors for repeated measurements, having the (EG and PG) group and the time (pre and post exercise). Level of significance adopted was P \< 0,05.

Interventions

OTHERExercise group

Resistance training 3 times per week (45-60 minutes of resistance training)

Sponsors

State University of Maringá
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Blood collections and subsequent analyzes were done blindly.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnostic for HIV/AIDS. * Clinical condition and viral count stabilized. * Have been using (HAART) for 6 months or more. * Not have participated in physical exercise programs in six months before beginning of study. * Not have muscle or joint injuries that make it impossible to practice physical activity. * Not be pregnant.

Exclusion criteria

* Not attending more than 15% of the intervention sessions or visits to the laboratory. * Aggravation of the disease. * Stick to a physical activity program in addition to that offered by the study.

Design outcomes

Primary

MeasureTime frameDescription
Change in Cognitive FunctionBaseline and eight weeksVictoria Stroop, Castro Cunha & Martins Stroop and Trail Test were performed at baseline and after eight weeks of intervention in both groups (EG and CG). Blood will be collected and brain-derived neurotrophic factor (BDNF) will be measured by Enzyme-Linked Immunosorbent Assay Method (Human - ELISA Kit) at baseline and after eight weeks of intervention in both groups (EG and CG).

Secondary

MeasureTime frameDescription
CD4 / CD8Baseline and eight weeksBlood was collected and cluster of differentiation 4 (T CD4+) and cluster of differentiation 8 (T CD8+) cells was measured by flow cytometry (BD TrucountTM Tubes) with FACSCalibur (Dickinson, New Jersey, USA) at baseline and after eight weeks of intervention in both groups (EG and CG).
Concentration of Inflammatory markersBaseline and eight weeksBlood was collected and interferon (INF-y), interleukin 4 (IL-4), interleukin 6 (IL-6) and interleukin 10 (IL-10) was be measured by Enzyme-Linked Immunosorbent Assay Method (Human - ELISA Kit) at baseline and after eight weeks of intervention in both groups (EG and CG).
Health cellularBaseline and eight weeksCellular health was evaluated through phase angle value using the bio-electrical bioimpedance method (Biodynamics 450 analyzer, Biodynamics Corporation, Seattle, USA) at baseline and after eight weeks of intervention in both groups (EG and CG).

Other

MeasureTime frameDescription
Change in handgrip strengthBaseline and eight weeksHandgrip strength was evaluated by handgrip dynamometer at baseline and after eight weeks of intervention in both groups (EG and CG).
Change in body compositionBaseline and eight weeksBody composition was evaluated at baseline and after eight weeks of intervention in both groups (EG and CG) using thickness of skin folds (Lange Adipometer). The skin folds of the triceps, subscapular, supra iliac, abdominal, thigh and leg were collected. The data were inserted into formulas appropriate to the population studied for calculating body composition.
Training load controlBaseline and eight weeksTraining load control was done by weekly monitoring and adjustment of the weights (kg) used in each exercise.
Change in flexibilityBaseline and eight weeksFlexibility was evaluated by sit and reach test at baseline and after eight weeks of intervention in both groups (EG and CG).
Change in body circumferencesBaseline and eight weeksPerimeters of arms, chest, abdomen, waist, hip, thigh and leg were measured at baseline and after eight weeks of intervention in both groups (EG and CG).
Change brachial blood pressureBaseline and eight weeksBrachial blood pressure (systolic and diastolic pressures) was assessed through an automatic monitor (HEM-742, Omron Healthcare, Japan) at baseline and after eight weeks of intervention in both groups (EG and CG).
Change autonomic cardiac modulationBaseline and eight weeksThe autonomic cardiac modulation was evaluated through a heart rate monitor (Polar, model RS-800, USA) at baseline and after eight weeks of intervention in both groups (EG and CG).

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026